Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Oncology

Arizona Blood & Cancer Specialists, OneOncology & TMC Healthcare Open Two Radiation Oncology Centers

Arizona Blood and Cancer Specialists (ABCS), OneOncology, and TMC HealthCare (TMC) today announced that through their joint venture, they have […]

Arizona Blood & Cancer Specialists, OneOncology & TMC Healthcare Open Two Radiation Oncology Centers
3 hours ago
Share

Memorial Sloan Kettering Study Takes on Esophagus Cancer with Combo of Chemo, PD-1 Blocker & Tyrosine Kinase Inhibitor

Memorial Sloan Kettering Cancer Center announced the launch of a Phase 2 study led by Yelena Y. Janjigian and Smita Joshi, which […]

Memorial Sloan Kettering Study Takes on Esophagus Cancer with Combo of Chemo, PD-1 Blocker & Tyrosine Kinase Inhibitor
2 days ago
Share

Parker Institute for Cancer Immunotherapy Awards $3m to Early Career Investigators in Ongoing Fight Against Cancer Thanks to Tech Riches

The Parker Institute for Cancer Immunotherapy (PICI) recently announced its 2021 class of early career researcher award recipients, a group […]

Parker Institute for Cancer Immunotherapy Awards $3m to Early Career Investigators in Ongoing Fight Against Cancer Thanks to Tech Riches
3 days ago
Share

BlossomHill Therapeutics Completes $71M Series A Round to Progress Pipeline of Small Molecule Drugs for Oncology, Autoimmune Disorders

BlossomHill Therapeutics raised $71 million in a Series A financing round, led by Cormorant Asset Management LLC and joined by Hercules BioVentures […]

BlossomHill Therapeutics Completes $71M Series A Round to Progress Pipeline of Small Molecule Drugs for Oncology, Autoimmune Disorders
3 days ago
Share

University of Kansas Cancer Center Introduces the Next Level App Supporting the Growing Clinical Research as a Care Option Advance

The University of Kansas Cancer Center has developed a new mobile app to match anyone looking for specific cancer trials with […]

University of Kansas Cancer Center Introduces the Next Level App Supporting the Growing Clinical Research as a Care Option Advance
1 week ago
Share

UNSW & Garvan Institute Take Precision Medicine Revolution to War Against Pancreatic Cancer in Australia

Thanks to an $3.75 million grant injection from the Cancer Institute, NSW Translational Program, researchers and clinicians from UNSW and […]

UNSW & Garvan Institute Take Precision Medicine Revolution to War Against Pancreatic Cancer in Australia
1 week ago
Share

$250m Philanthropic Capital Infusion Launches Break Through Cancer Targeting Cures for Most Intractable Cancers

One of the largest gifts, even in support of cancer research, $250 million thanks to Mr. and Mrs. William H. […]

$250m Philanthropic Capital Infusion Launches Break Through Cancer Targeting Cures for Most Intractable Cancers
1 week ago
Share

UCSF Develops Research as a Care Option Decision, Supporting Tool for Prostate Cancer Patients

One of the biggest challenges facing clinical trial sponsors and investigational sites centers on the efficient identification, recruitment and ongoing […]

UCSF Develops Research as a Care Option Decision Support Tool for Prostate Cancer Patients
2 weeks ago
Share

AstraZeneca’s Phase 3 KESTREL Trial of Imfinzi Fails to Meet the Primary Endpoint in Patients with Head and Neck Cancer

AstraZeneca reported that its Phase 3 KESTREL trial of Imfinzi (durvalumab) failed to meet the primary endpoint of improving overall […]

AstraZeneca’s Phase 3 KESTREL Trial of Imfinzi Fails to Meet the Primary Endpoint in Patients with Head and Neck Cancer
3 weeks ago
Share

Regeneron’s Libtayo Approved by the FDA as First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma

The U.S. Food and Drug Administration granted approval of a drug that is the first immunotherapy treatment indicated for patients […]

Regeneron’s Libtayo Approved by the FDA as First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma
3 weeks ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.